Does biologic survival depend on co-prescribed methotrexate dose in established rheumatoid arthritis? A real-world study
Main Authors: | Nadira B. Mothojakan, Janki Gore, Muhammad K. Nisar |
---|---|
Format: | Article |
Language: | English |
Published: |
AVES
2020-01-01
|
Series: | European Journal of Rheumatology |
Online Access: | https://www.eurjrheumatol.org/en/does-biologic-survival-depend-on-co-prescribed-methotrexate-dose-in-established-rheumatoid-arthritis-a-real-world-study-133263 |
Similar Items
-
Real‐World Adherence to Oral Methotrexate Measured Electronically in Patients With Established Rheumatoid Arthritis
by: Kaleb Michaud, et al.
Published: (2019-11-01) -
Dose Adjustment of Methotrexate Administered Concomitantly with Golimumab for Rheumatoid Arthritis in Japanese Real-World Clinical Settings
by: Fumiko Yamairi, et al.
Published: (2020-08-01) -
Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
by: Takeo Isozaki, et al.
Published: (2010-07-01) -
Methotrexate and The Lung in Rheumatoid Arthritis
by: Shamma Ahmad Al Nokhatha, et al.
Published: (2020-07-01) -
Methotrexate in Treatment of Rheumatoid Arthritis
by: Wiewiόrowski Maciej, et al.
Published: (1999-08-01)